Bloom Energy’s Rally Meets a Hard Deadline as AI Demand and Legal Risk Collide
Published on 08/12/2026 at 18:13 | Redaktion boerse-global.de
Bloom Energy has given investors two very different reasons to pay attention: a record quarter that pushed revenue above the $1 billion mark, and a September 28 deadline that could shape the next phase of its legal overhang. The stock has been rewarded for the growth story, but the market is also being asked to weigh a class-action case tied to the company’s disclosure around scandium.
The latest business figures were hard to ignore. In the second quarter, revenue surged to $1.065 billion, up 165.5 percent from the same period a year earlier and the company’s first billion-dollar quarter. Operating profit came in at $182.2 million, while gross margin improved by 668 basis points to 33.4 percent. Bloom also raised its full-year sales outlook to $3.9 billion to $4.2 billion, from a prior range of $3.4 billion to $3.8 billion.
That momentum has been reflected in the share price. On the German market, Bloom Energy stock traded at EUR201.50 after a 9.0 percent jump in a single session. Even so, it remains 34.7 percent below its 52-week high of EUR308.50, and the recent legal noise has weighed on the chart. The shares were quoted at EUR184.80 on Tuesday, up 1.32 percent on the day, but still down 10.29 percent over 30 days and 40.10 percent below the 52-week peak. They also sit under the 50-day average of EUR219.16.
A big part of the market’s enthusiasm comes from Bloom’s role in AI infrastructure. At the start of August, the company expanded its partnership with MiTAC Computing Technology Corp. to include a fuel-cell microgrid for an AI server manufacturing campus in Fremont, California. Bloom says it now serves nearly two dozen AI infrastructure customers with roughly 250 megawatts of contracted capacity, up from effectively zero two years ago.
The financing side has become just as important as the technology itself. Bloom’s deeper relationship with Brookfield Asset Management has lifted available project financing to $25 billion, underlining how much the business model depends on scaling through external capital. Chief executive K.R. Sridhar said in early August that Bloom had become “a standard for on-site power for AI,” a confident claim the market has been willing to entertain.
Should investors sell immediately? Or is it worth buying Bloom Energy?
Wall Street, however, is not speaking with one voice. In late July, Mizuho upgraded the shares from Neutral to Outperform and set a $242 target, down from $285, pointing to early-operating leverage and more than $27 billion in available financing capacity for customer projects. JPMorgan kept its Overweight rating but trimmed its target to $314 from $346. Wells Fargo stayed cautious with an Equal Weight rating and cut its target to $176 from $217, citing possible turbine-capacity constraints after 2030.
The legal case has its own timeline. Three law firms — Pomerantz LLP, Levi & Korsinsky LLP and Kaplan Fox & Kilsheimer LLP — have each issued notices telling investors they can seek appointment as lead plaintiff in a class action against Bloom Energy by September 28, 2026. The proposed class period runs from February 27, 2025 to July 8, 2026.
At the center of the complaint is the allegation that Bloom Energy did not adequately disclose its dependence on Chinese scandium. That issue came into sharper focus after Hunterbrook Media published “Bloom’s Big Lie” on July 8, raising questions about the company’s supply chain for the critical metal. Bloom’s shares fell 5.67 percent, or $15.28, to $254.29 that day.
Scandium matters because it is a key material in Bloom’s fuel-cell technology. The controversy has also been amplified by policy developments far beyond the company itself. On August 7, the Trump administration announced a more than $2 billion program to support domestic production of critical minerals, including $400 million for a scandium mine owned by Australia’s Sunrise Energy Metals. Separately, NioCorp Developments and Lockheed Martin are discussing a possible supply of up to 15 tons of scandium oxide a year from the Elk Creek project in Nebraska.
Insider activity has added another layer of scrutiny, though not necessarily the kind that signals panic. Over the past 90 days, company insiders sold about $9.97 million worth of stock, including transactions by the chief commercial officer and chief operations officer. Those sales were made under pre-arranged 10b5-1 trading plans established in November 2025, so they were scheduled diversification rather than a fresh vote of no confidence. There were no insider purchases during the same period.
Dilution remains part of the investment case as well. Bloom’s share count rose 23 percent over the past year, a reminder that the company’s expansion has not come free of equity issuance.
The longer-term performance still looks extraordinary. Year to date, the stock is up 146.24 percent, and over 12 months it has gained 422.77 percent. That strength leaves the current dispute over scandium and disclosure hanging over a name that is still very much in the market’s good graces, even if the next court deadline is now just around the corner.
Ad
Bloom Energy Stock: New Analysis - 12 August
Fresh Bloom Energy information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
